Adani Medicity And Research Center Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -74.79%
(FY 2023)
- Profit -195.70%
(FY 2023)
- Ebitda 61.84%
(FY 2023)
- Net Worth -62.51%
(FY 2023)
- Total Assets -60.29%
(FY 2023)
About Adani Medicity And Research Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pritiben Adani, Prashant Jhaveri, Malay Mahadevia, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300GJ2021NPL123901
- Company No.
123901
- Company Classification
Private Not For Profit Company
- Incorporation Date
07 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Adani Medicity And Research Center?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Jhaveri  | Additional Director | 28-Oct-2024 | Current |
| Malay Mahadevia | Additional Director | 28-Oct-2024 | Current |
| Gautam Adani | Director | 07-Jul-2021 | Current |
| Pritiben Adani | Director | 07-Jul-2021 | Current |
Financial Performance of Adani Medicity And Research Center.
Adani Medicity And Research Center, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.79% decrease. The company also saw a substantial fall in profitability, with a 195.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 62.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adani Medicity And Research Center?
In 2023, Adani Medicity And Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adani Ports And Special Economic Zone LimitedActive 26 years 6 monthsGautam Adani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adani Medicity And Research Center?
Adani Medicity And Research Center has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adani Medicity And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adani Medicity And Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
